AJHO | Gotoper.com

SUN	MON	TUES	WED	THURS	FRI	SAT
				1	2	3 Proteolysis-Targeting Chimera (PROTAC) Therapy for Cancer Expires on Dec 03, 2022 CME 0.5
4	5	6	7	8 PER® Postgame™: Reporting the Latest Global Updates Across the Treatment of Breast Cancer Expires on Dec 08, 2022 CME 1.5 Oncology Consultations®: Critical Conversations for Treating sAML in the Outpatient Setting Expires on Dec 08, 2022 CME 1.0	9	10
11	12	13 Oncology Briefings™: Updates in the Treatment of GEP-NETs Expires on Dec 13, 2022 CME 1.0	14	15 Advances in™: Application of Proteasome Inhibitor Therapies Across the MM Disease Spectrum Expires on Dec 15, 2022 CME 1.5 Virtual Hot Seat™: Experts Face Key Questions to Maximize the Use of PI3K Inhibitors Across Hematologic Malignancies Expires on Dec 15, 2022 CME 1.5 Show Me Your Care Plan! Managing Adverse Events Associated with CAR T-Cell Therapies for Oncology Nurses Expires on Dec 15, 2022 CME	16	17 Community Practice Connections: Making the Most of Effective Antithrombotic Strategies in Patients with CAD and PAD Expires on Dec 17, 2022 CME 1.0 Tardive Dyskinesia: Moving Management Forward Expires on Dec 17, 2022 CME 1.0
18	19	20 Advances In™: Clinical Impact of Novel Emerging Treatment Options for PK Deficiency Expires on Dec 20, 2022 CME 1.0 Patient, Provider, and Caregiver Connection™: Limiting the Patient Burden of Neurotrophic Keratitis Expires on Dec 20, 2022 CME 1.5 DIAGNOSIS AND TREATMENT OF MF AND PV: Where Are We and Where Are We Going? Expires on Dec 20, 2022 CME 3.0	21 Community Practice Connections™: Optimizing Management of Uveitic Macular Edema With Potential Treatments on the Horizon Expires on Dec 21, 2022 CME 1.0 BURST CME™: Deciphering Clinical Trial Endpoints Amidst an Advent of Novel Therapies for Low- to High-Risk MDS Expires on Dec 21, 2022 CME 0.5	22 Oncology Consultations™: How Do The Experts Utilize PARP Inhibitors in Ovarian Cancer Across Lines of Care? Expires on Dec 22, 2022 CME 2.0 Advances In™ Marginal Zone Lymphoma: Applying New Developments to Practice Expires on Dec 22, 2022 CME 1.5 Advances in™ Beta-Thalassemia: The Evolving Therapeutic Landscape Expires on Dec 22, 2022 CME 1.0 Advances In™: How the Experts Treat Oncogene-Driven Advanced NSCLC Expires on Dec 22, 2022 CME 1.5 Continuity in Care®: Best Practices in Immunoglobulin Therapy—Improving Quality of Life for Patients With Primary Immunodeficiency Expires on Dec 22, 2022 CME 1.5 PER Postgame™: Protecting Patients with MS from COVID-19—Exploring the Latest in Prevention and Immunosuppressive Treatment Strategies Expires on Dec 22, 2022 CME 1.25 PER® Postgame: Breaking Down the Latest Data and Updates in Anemia of Chronic Kidney Disease – Fall 2021 Nephrology Meeting Takeaways Expires on Dec 22, 2022 CME 1.25 Elucidating Novel BTKi Strategies in CLL/SLL and MCL: A Virtual Exploration to Bring Therapeutic Rationales and Evidence into Perspective Expires on Dec 22, 2022 CME 3.0 Expert Illustrations & Commentaries™: Roles and Rationales for BCMA-Directed Therapies in Multiple Myeloma Expires on Dec 22, 2022 CME 1.0	23 Oncology Consultations®: Addressing the Risk and Burden of CNS Metastases in HER2+ Breast Cancer to Improve Patient Outcomes Expires on Dec 23, 2022 CME 1.0 Oncology Consultations®: Applying the Latest Advances in Treatment of PTCL and CTCL with an Eye Toward the Future of Care Expires on Dec 23, 2022 CME 1.0 Advances in™: Diagnosis and Treatment of BPDCN Around the World! Expires on Dec 23, 2022 CME 1.5 Medical Crossfire®: Sequencing of Disease Modifying Therapies – Optimizing Outcomes in Patients with Multiple Sclerosis Expires on Dec 23, 2022 CME 1.0 Medical Crossfire®: Personalized Regimens for Managing Hemophilia A: Selecting an Optimal Recombinant FVIII Agent Expires on Dec 23, 2022 CME 1.5 Medical Crossfire®: Applying the Evidence in Acute Lymphoblastic Leukemia From Pediatric to Adult Case Scenarios Expires on Dec 23, 2022 CME 2.0 Medical Crossfire^®: Bridging The Gap Between Diagnosis and Treatment in Hemolytic Anemias Expires on Dec 23, 2022 CME 1.5 Community Practice Connections™: Bridging Clinical Gaps and Disparities in Care in TNBC Expires on Dec 23, 2022 CME 1.0 NSCLC TUMOR BOARD: Multimodal Approaches to Optimize Immune Checkpoint Inhibition Strategies in Curative Settings Expires on Dec 23, 2022 CME 2.0 2nd Annual Virtual Tumor Board®: Navigating Novel Therapeutic Approaches for the Management of SCLC Across Lines of Care Expires on Dec 23, 2022 CME 1.5 Cancer Summaries and Commentaries: Report from Atlanta on Advances in the Treatment of DLBCL Expires on Dec 23, 2022 CME 2.0 New Targets, New Combinations, New Treatment Goals: Assessing Therapeutic Options to Personalize Care in Multiple Myeloma Expires on Dec 23, 2022 CME 2.0 PEeR Exchange® Assessing Racial and Ethnic Disparities in Lung Cancer Care Expires on Dec 23, 2022 CME 1.5 Clinical ShowCase™: Optimizing Care from Start to Finish for Patients with ESRD Requiring Renal Transplantation Expires on Dec 23, 2022 CME 0.75 Expert Illustrations & Commentaries™: Visualizing Corneal Innervation, Pathophysiology, and Treatment Mechanisms in Neurotrophic Keratitis Expires on Dec 23, 2022 CME 1.5	24
25	26	27	28	29	30	31